[Home](../../main.md) | [Prev: Day 82](notes_2025-02-07.md) | [Next: Day 84](./notes_2025-02-11.md)

## üìù Day 83, Monday - `notes_2025-02-10.md`


- US204:
    * use of sql

```sql
SELECT * 
FROM eln_writeup_comparison 
WHERE diff LIKE '%?%' 
AND analysis_date = '2025-02-05' 
AND diff NOT LIKE '%(? mg, ? mmol,%';
```


```diff
--- 
+++ 
@@ -1 +1 @@
-1-(cyanomethyl)-N-methyl-N-[(1-methylpyrazol-4-yl)methyl]-4-[rac-(3R)-3-methyl-2,3-dihydro-1H-indol-4-yl]indazole-7-carboxamide (30.0 mg, 0.07 mmol){{9:uid 1}}_XXXXX_   and Methyl 4,6-dichloro-3-pyridazinecarboxylate (21.19 mg, 0.1 mmol){{9:uid 2}}_XXXXX_    dissolved in MeCN (1 mL){{3:uid 1}}_XXXXX_    Add N,N-Diisopropylethylamine (0.06 mL, 0.34 mmol){{9:uid 3}}_XXXXX_    stir at r.t. stir at r.t. small amount of rxn but not much heat to 60 C overnight ~70% stirred another 24 hours to complete reaction concentrated purified to obtain methyl 6-chloro-4-[rac-(3R)-4-[1-(cyanomethyl)-7-[methyl-[(1-methylpyrazol-4-yl)methyl]carbamoyl]indazol-4-yl]-3-methyl-2,3-dihydroindol-1-yl]pyridazine-3-carboxylate (19 mg, 0.03114 mmol, 45.627% yield){{2:uid 1}}_XXXXX_   M+1 = 610.3 found
+1-(cyanomethyl)-N-methyl-N-[(1-methylpyrazol-4-yl)methyl]-4-[rac-(3R)-3-methyl-2,3-dihydro-1H-indol-4-yl]indazole-7-carboxamide (30.0 mg, 0.07 mmol){{9:uid 1}}_XXXXX_   and Methyl 4,6-dichloro-3-pyridazinecarboxylate (21.19 mg, 0.1 mmol){{9:uid 2}}_XXXXX_    dissolved in MeCN (1 mL){{3:uid 1}}_XXXXX_    Add N,N-Diisopropylethylamine (0.06 mL, 0.34 mmol){{9:uid 3}}_XXXXX_    stir at r.t. stir at r.t. small amount of rxn but not much heat to 60 C overnight ~70% stirred another 24 hours to complete reaction concentrated purified to obtain methyl 6-chloro-4-[rac-(3R)-4-[1-(cyanomethyl)-7-[methyl-[(1-methylpyrazol-4-yl)methyl]carbamoyl]indazol-4-yl]-3-methyl-2,3-dihydroindol-1-yl]pyridazine-3-carboxylate (? mg, ? mmol, ?% yield){{2:uid 1}}_XXXXX_   M+1 = 610.3 found


--- 
+++ 
@@ -1 +1 @@
-A mixture of (2S,6R)-6-[(6-bromo-1-oxospiro[3H-isoquinoline-4,1'-cyclopropane]-2-yl)methyl]-N,N-dimethyloxane-2-carboxamide (‚Äã20.0 mg, ‚Äã0.05 mmol)‚Äã{{1080:uid 1}}_XXXXX_  , [3-[(2-aminopyrido[3,2-d]pyrimidin-4-yl)amino]-2-methoxyphenyl]boronic acid (‚Äã20.68 mg, ‚Äã0.07 mmol)‚Äã{{1080:uid 2}}_XXXXX_  , Xphos Pd G2 (‚Äã7.47 mg, ‚Äã0.01 mmol)‚Äã{{1080:uid 3}}_XXXXX_   and CsOAc (‚Äã18.22 mg, ‚Äã0.09 mmol)‚Äã{{1080:uid 4}}_XXXXX_  in 1,4-Dioxane (1 mL){{3:uid 1}}_XXXXX_   and Water (60 uL){{3:uid 2}}_XXXXX_  was purged with N2 for 1 mins. The reaction was stirred at 100 ¬∞C overnight. The reaction was cooled to rt and was poured into brine. The mixture was extracted by DCM/MeOH (v/v=15/1) three times.  The combined organic phase was dried over Na2SO4. After removal of solvent, the residue was purified by prep-HPLC on C18 column (30 x 250 mm, 10 Œºm) using mobile phase 15% to 40% MeCN/H2O (w/ 0.05% TFA) (tR = 18 min). The desired fractions were collected, concentrated and freeze-dried to give (2S,6R)-6-[[6-[3-[(2-aminopyrido[3,2-d]pyrimidin-4-yl)amino]-2-methoxyphenyl]-1-oxospiro[3H-isoquinoline-4,1'-cyclopropane]-2-yl]methyl]-N,N-dimethyloxane-2-carboxamide (? mg, ? mmol, ?% yield){{2:uid 1}}_XXXXX_  as white solids. LC-MS calc. for C34H38N7O4 [MS+H]+:608.3 ;Found:608.5.
+A mixture of (2S,6R)-6-[(6-bromo-1-oxospiro[3H-isoquinoline-4,1'-cyclopropane]-2-yl)methyl]-N,N-dimethyloxane-2-carboxamide (20.0 mg, 0.05 mmol){{9:uid 1}}_XXXXX_  , [3-[(2-aminopyrido[3,2-d]pyrimidin-4-yl)amino]-2-methoxyphenyl]boronic acid (20.68 mg, 0.07 mmol){{9:uid 2}}_XXXXX_  , Xphos Pd G2 (7.47 mg, 0.01 mmol){{9:uid 3}}_XXXXX_   and CsOAc (18.22 mg, 0.09 mmol){{9:uid 4}}_XXXXX_  in 1,4-Dioxane (1 mL){{3:uid 1}}_XXXXX_   and Water (60 uL){{3:uid 2}}_XXXXX_  was purged with N2 for 1 mins. The reaction was stirred at 100 ¬∞C overnight. The reaction was cooled to rt and was poured into brine. The mixture was extracted by DCM/MeOH (v/v=15/1) three times.  The combined organic phase was dried over Na2SO4. After removal of solvent, the residue was purified by prep-HPLC on C18 column (30 x 250 mm, 10 Œºm) using mobile phase 15% to 40% MeCN/H2O (w/ 0.05% TFA) (tR = 18 min). The desired fractions were collected, concentrated and freeze-dried to give (2S,6R)-6-[[6-[3-[(2-aminopyrido[3,2-d]pyrimidin-4-yl)amino]-2-methoxyphenyl]-1-oxospiro[3H-isoquinoline-4,1'-cyclopropane]-2-yl]methyl]-N,N-dimethyloxane-2-carboxamide (? mg, ? mmol, ?% yield){{2:uid 1}}_XXXXX_  as white solids. LC-MS calc. for C34H38N7O4 [MS+H]+:608.3 ;Found:608.5.

--- 
+++ 
@@ -1 +1 @@
-To a mixture of tert-butyl N-[1-[1-(benzenesulfonyl)-5-methoxypyrrolo[2,3-b]pyridin-4-yl]-3,4-dihydro-2H-quinolin-4-yl]carbamate (32.0 mg, 0.06 mmol){{9:uid 29}}_XXXXX_   in THF (2 mL){{3:uid 1}}_XXXXX_  was added dropwise Lithium Diisopropylamide (0.04 mL, 0.08 mmol){{9:uid 31}}_XXXXX_  at -78 ¬∞C{{8:row 1}}_XXXXX_  . After stirring for 30 min, to the mixture was added a solution of 1,2-Dibromotetrachloroethane (29.24 mg, 0.09 mmol){{9:uid 30}}_XXXXX_  in THF (1 mL){{3:uid 2}}_XXXXX_ . The mixture was stirred at -78 ¬∞C{{8:row 1}}_XXXXX_  for 30 min, then quenched with aq. sat. NH4Cl solution. concentrated and purified on FCC (0-100% EtOAc/Hex) to give tert-butyl N-[1-[1-(benzenesulfonyl)-2-bromo-5-methoxypyrrolo[2,3-b]pyridin-4-yl]-3,4-dihydro-2H-quinolin-4-yl]carbamate (? mg, ? mmol, ?% yield){{2:uid 1}}_XXXXX_  . LCMS [M+H] 216.2.  
+To a mixture of 4-bromo-6-chloro-3-methoxypyridazine (140.0 mg, 0.63 mmol){{9:uid 22}}_XXXXX_   in DMF (4 mL){{3:uid 1}}_XXXXX_  was added dropwise 3-Bromo-2-methoxyaniline (101.27 uL, 0.75 mmol){{9:uid 25}}_XXXXX_   at 0 ¬∞C{{8:row 1}}_XXXXX_  . The mixture was stirred for 2h. LCMS showed no formation of N-(3-bromo-2-methoxyphenyl)-6-chloro-3-methoxypyridazin-4-amine (? mg, ? mmol, ?% yield){{2:uid 1}}_XXXXX_  .

--- 
+++ 
@@ -1 +1 @@
-To a 250 mL RBF was added (4-Chloro-2-pyridinyl)methanol (‚Äã20.0 mg, ‚Äã0.14 mmol)‚Äã{{1080:uid 1}}_XXXXX_   and a magnetic stir bar. The chloride was dissolved in ? (? ?){{3:uid 1}}_XXXXX_   and to this was added Pyridine 4-boronic acid (‚Äã35.96 mg, ‚Äã0.29 mmol)‚Äã{{1080:uid 2}}_XXXXX_   and ? (‚Äã?, ‚Äã? mmol)‚Äã{{1080:uid 3}}_XXXXX_  , respectively. The vessel was sealed and flushed with nitrogen gas for 20 mins, after which Potassium Carbonate (‚Äã57.76 mg, ‚Äã0.42 mmol)‚Äã{{1080:uid 4}}_XXXXX_   was added and flushed for an additional 10 mins. The reaction was heated to 95¬∞C and allowed to stir overnight. The HPLC and LCMS showed consumption of the desired product, and formation of the desired product. The reaction will be combined with a scaled-up batch (RRJ03-65) for workup and purification. 
+To a 250 mL RBF was added (4-Chloro-2-pyridinyl)methanol (20.0 mg, 0.14 mmol){{9:uid 1}}_XXXXX_   and a magnetic stir bar. The chloride was dissolved in ? (? ?){{3:uid 1}}_XXXXX_   and to this was added Pyridine 4-boronic acid (35.96 mg, 0.29 mmol){{9:uid 2}}_XXXXX_   and ? (?, ? mmol){{9:uid 3}}_XXXXX_  , respectively. The vessel was sealed and flushed with nitrogen gas for 20 mins, after which Potassium Carbonate (57.76 mg, 0.42 mmol){{9:uid 4}}_XXXXX_   was added and flushed for an additional 10 mins. The reaction was heated to 95¬∞C and allowed to stir overnight. The HPLC and LCMS showed consumption of the desired product, and formation of the desired product. The reaction will be combined with a scaled-up version for workup and purification. 
```

- write sql for Genaro to get group and project and user:

```sql
SELECT 
    g.GROUP_NAME, 
    u.ISID, 
    u.CREATED_DATE,
    g.TM_GROUP_ID, 
    g.REGISTER,
    u.COUNTERSIGN, 
    u.GROUP_ADMIN
FROM 
    DS3_USERDATA.TM_GROUPS g
JOIN 
    DS3_USERDATA.TM_GROUPS_USERS u 
    ON g.TM_GROUP_ID = u.TM_GROUP_ID
order by isid, group_name

-- project level
with t as (select
a.isid,  
b.name,
c.project_name,
b.created_date
from tm_project_user_access a
join tm_projects b on
a.project_id = b.id
join (select distinct id, project_name from project_list) c on
b.name = c.id
)
select * from t
order by t.isid

-- better consolidated version, however duplicates project names based on group names:

WITH project_info AS (
    SELECT 
        a.isid,  
        b.name AS project_id, 
        c.project_name,
        b.created_date
    FROM DS3_USERDATA.TM_PROJECT_USER_ACCESS a
    JOIN DS3_USERDATA.TM_PROJECTS b 
        ON a.project_id = b.id
    JOIN (SELECT DISTINCT id, project_name FROM DS3_USERDATA.PROJECT_LIST) c 
        ON b.name = c.id
)
SELECT 
    u.ISID, 
    g.GROUP_NAME, 
    g.TM_GROUP_ID, 
    g.REGISTER, 
    u.COUNTERSIGN, 
    u.GROUP_ADMIN, 
    p.project_name, 
    p.created_date
FROM DS3_USERDATA.TM_GROUPS_USERS u
JOIN DS3_USERDATA.TM_GROUPS g 
    ON g.TM_GROUP_ID = u.TM_GROUP_ID
LEFT JOIN project_info p 
    ON u.ISID = p.isid
ORDER BY u.ISID, g.GROUP_NAME, p.project_name
```

- ran `test_compare_dm_api.py` again with 14 writeup samples that were copied from diff column in psql database
    * data still shows trend that the pre-processing text step does not significantly impact the comparison metric results
    * made changes to output side by side for easier comparison
